| Community-led, integrated, reproducible multi-omics with anvi’o AM Eren, E Kiefl, A Shaiber, I Veseli, SE Miller, MS Schechter, I Fink, ... Nature microbiology 6 (1), 3-6, 2021 | 436 | 2021 |
| Functional and genetic markers of niche partitioning among enigmatic members of the human oral microbiome A Shaiber, AD Willis, TO Delmont, S Roux, LX Chen, AC Schmid, ... Genome biology 21, 1-35, 2020 | 147 | 2020 |
| Community-led, integrated, reproducible multi-omics with anvi’o. Nat Microbiol 6: 3–6 AM Eren, E Kiefl, A Shaiber, I Veseli, SE Miller, MS Schechter, I Fink, ... | 73 | 2021 |
| Early-Life Microbial Restitution Reduces Colitis Risk Promoted by Antibiotic-Induced Gut Dysbiosis in Interleukin 10–/–Mice J Miyoshi, S Miyoshi, TO Delmont, C Cham, STM Lee, A Sakatani, K Yang, ... Gastroenterology 161 (3), 940-952. e15, 2021 | 23 | 2021 |
| The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: a systematic review A Sarkar, S Omar, A Alshareef, K Fanous, S Sarker, H Alroobi, F Zamir, ... Human Vaccines & Immunotherapeutics 19 (1), 2212568, 2023 | 16 | 2023 |
| Statistically learning the functional landscape of microbial communities A Skwara, K Gowda, M Yousef, J Diaz-Colunga, AS Raman, A Sanchez, ... Nature Ecology & Evolution 7 (11), 1823-1833, 2023 | 12 | 2023 |
| Community-led, integrated, reproducible multi-omics with anvi’o. Nat Microbiol. 2021; 6: 3–6 AM Eren, E Kiefl, A Shaiber, I Veseli, SE Miller, MS Schechter, I Fink, ... | 10 | |
| Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma A Yousef, M Yousef, S Chowdhury, K Abdilleh, M Knafl, P Edelkamp, ... NPJ Precision Oncology 8 (1), 27, 2024 | 4 | 2024 |
| Transient suppression of bacterial populations associated with gut health is critical in success of exclusive enteral nutrition for children with crohn’s disease J Runde, I Veseli, EC Fogarty, AR Watson, Q Clayssen, M Yosef, ... Journal of Crohn's and Colitis 17 (7), 1103-1113, 2023 | 2 | 2023 |
| Learning the functional landscape of microbial communities A Skwara, K Gowda, M Yousef, J Diaz-Colunga, AS Raman, A Sanchez, ... bioRxiv, 2023.03. 24.534159, 2023 | 2 | 2023 |
| Impact of KRAS Mutations and Co-mutations on Clinical Outcome in Pancreatic Ductal Adenocarcinoma D Zhao, A Yousef, M Yousef, S Chowdhury, K Abdilleh, M Knafl, ... | 1 | 2023 |
| Early-life microbial intervention reduces colitis risk promoted by antibiotic-induced gut dysbiosis J Miyoshi, S Miyoshi, TO Delmont, C Cham, STM Lee, A Sakatani, K Yang, ... bioRxiv, 2020.03. 11.987412, 2020 | 1 | 2020 |
| Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers E Belmont, VV Bansal, MMG Yousef, MA Zeineddine, D Su, A Dhiman, ... JCO Precision Oncology 8, e2300531, 2024 | | 2024 |
| Cell-type-specific gene programs suggest immune and stromal drivers of relapse in colorectal cancer NJ Hornstein, M Wang, A Yousef, S Chowdhury, F Zeineddine, ... Cancer Research 84 (6_Supplement), 881-881, 2024 | | 2024 |
| KRAS Q61 mutations in patients with gastrointestinal malignancies and association with real-world clinical outcomes M Yousef, A Yousef, S Chowdhury, MM Fanaeian, M Knafl, PM Roy, ... Cancer Research 84 (6_Supplement), 2547-2547, 2024 | | 2024 |
| The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review M Yousef, M Rob, S Varghese, S Rao, F Zamir, P Paul, A Chaari Life Sciences, 122535, 2024 | | 2024 |
| Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma A Yousef, M Yousef, MA Zeineddine, A More, M Fanaeian, S Chowdhury, ... JAMA Network Open 7 (2), e240260-e240260, 2024 | | 2024 |
| Risk of relapse after surgical resection of localized appendiceal adenocarcinoma. MM Fanaeian, MMG Yousef, AMG Yousef, WC Foo, M Taggart, KA Beaty, ... Journal of Clinical Oncology 42 (3_suppl), 58-58, 2024 | | 2024 |
| Single cell transcriptomic profiling of appendiceal adenocarcinoma to identify rare tumor cells and a myeloid-enriched tumor microenvironment (TME). BB Gunes, NJ Hornstein, M Wang, S Chowdhury, MMG Yousef, ... Journal of Clinical Oncology 42 (3_suppl), 760-760, 2024 | | 2024 |
| Frequency and oncologic outcomes of KRAS mutations in circulating tumor DNA of patients with pancreatic ductal adenocarcinoma. MMG Yousef, MW Hurd, AMG Yousef, RA Snyder, M Knafl, MM Fanaeian, ... Journal of Clinical Oncology 42 (3_suppl), 636-636, 2024 | | 2024 |
